• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 25 of 100
Pfizer pills
Health
Pfizer shares slide after it recalls blood pressure drug over cancer-risk fears
By Sophie MellorMarch 23, 2022
Ryan Hampton poses for a picture.
Health
‘It felt like we were talking to statues’: An OxyContin addict who confronted the Sackler family about opioids reveals their stoicism
By Carmela ChirinosMarch 16, 2022
Europeans are so scared of a nuclear attack they’re panic buying iodine tablets
Health
Europeans are so scared of a nuclear attack they’re panic buying iodine tablets
By Christiaan HetznerMarch 8, 2022
A box of Paxlovid, antiviral medication
Commentary
Lawmakers want to weaken U.S. patents that made new anti-COVID pills possible. We should do everything to protect them
By Andrei Iancu, David J. Kappos and Paul R. MichelMarch 4, 2022
Pharma’s sense of urgency must outlast the pandemic
Commentary
Pharma’s sense of urgency must outlast the pandemic
By Paul HudsonFebruary 22, 2022
Elderly man holding his medicine
Health
Inside the lobbying push to get Medicare to pay for a controversial Alzheimer’s drug
By Arthur Allen and Kaiser Health NewsFebruary 16, 2022
A pharmacy technician at work in Utah
Commentary
Democrats must get their act together, starting with drug prices
By Howard DeanFebruary 3, 2022
Inequity in health care made the AIDS crisis worse. Why are we making the same mistake with COVID-19?
Commentary
Inequity in health care made the AIDS crisis worse. Why are we making the same mistake with COVID-19?
By Jennifer LotitoJanuary 31, 2022
There’s a silent epidemic killing over 100,000 Americans a year, and the government is allowing the cure to get more and more expensive
Health
There’s a silent epidemic killing over 100,000 Americans a year, and the government is allowing the cure to get more and more expensive
By Andrew MarquardtJanuary 31, 2022
Bristol-Myers Squibb logo on a smartphone
Newsletters
What a Bristol-Myers project to monitor off-label prescribing says about future uses of A.I.
By Jeremy Kahn and Jonathan VanianJanuary 25, 2022
Pfizer’s vaccine didn’t just ward off COVID—it may have saved Germany’s economy last year
Health
Pfizer’s vaccine didn’t just ward off COVID—it may have saved Germany’s economy last year
By Christiaan HetznerJanuary 21, 2022
Mark Cuban opens his own online pharmacy
Health
Mark Cuban opens his own online pharmacy
By Chris MorrisJanuary 20, 2022
Biogen building
Health
Medicare ordered to reassess premium hike for Alzheimer’s drug
By Ricardo Alonso-Zaldivar and The Associated PressJanuary 10, 2022
Gloved hand holding pills in front of Sanofi corporate logo
Health
Sanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion
By Jeremy KahnJanuary 7, 2022
World leaders should acknowledge that IP protections facilitate vaccine access
Commentary
World leaders should acknowledge that IP protections facilitate vaccine access
By Andrei IancuDecember 24, 2021
1...
  • 23
  • 24
  • 25
  • 26
  • 27
...100
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Personal Finance
Current price of oil as of July 1, 2026placeholder alt text
By Joseph HostetlerJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.